Susumu Tomono Selected Research

Susumu Tomono Research Topics

Disease

4	Atherosclerosis 07/2013 - 01/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2013 - 01/2011
3	Inflammation (Inflammations) 01/2020 - 05/2017
3	Carcinogenesis 01/2020 - 05/2017
3	Neoplasms (Cancer) 01/2020 - 07/2013
3	Intestinal Polyps 01/2020 - 02/2016
3	Colonic Neoplasms (Colon Cancer) 08/2017 - 10/2012
2	Dysbiosis 08/2021 - 01/2020
2	Polyps 01/2020 - 02/2016
1	Pneumonia (Pneumonitis) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Diarrhea 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Human Influenza (Influenza) 01/2020
1	Pruritus (Itching) 01/2020
1	Infections 01/2020
1	Blister (Bulla) 01/2020
1	Pain (Aches) 01/2020
1	Erythema 01/2020
1	Cognitive Dysfunction 07/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Aberrant Crypt Foci 08/2017
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2012
1	Septic Shock (Toxic Shock Syndrome) 12/2011
1	Alzheimer Disease (Alzheimer's Disease) 09/2011
1	Leukemia 01/2011

Drug/Important Bio-Agent (IBA)

4	CholesterolIBA 01/2021 - 01/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2021 - 05/2017
3	Messenger RNA (mRNA)IBA 01/2020 - 02/2016
3	secosterol-BIBA 01/2012 - 01/2011
2	protectin D1IBA 08/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 05/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2017
2	EnzymesIBA 01/2019 - 09/2012
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2017 - 05/2017
2	Interleukin-6 (Interleukin 6)IBA 05/2017 - 02/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2012 - 01/2012
2	AldehydesIBA 01/2012 - 01/2011
1	ChemokinesIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	palmitoleic acidIBA 01/2020
1	LipidsIBA 01/2020
1	AntioxidantsIBA 01/2020
1	CreatinineIBA 01/2020
1	5-hydroxy-1-methylhydantoinIBA 01/2020
1	Hydroxyl RadicalIBA 01/2020
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2020
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2020
1	Hemagglutinins (Hemagglutinin)IBA 01/2020
1	Bee Venoms (Bee Venom)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	AntibodiesIBA 01/2020
1	LignansIBA 07/2019
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	AllergensIBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 08/2017
1	LuciferasesIBA 08/2017
1	Anticarcinogenic AgentsIBA 08/2017
1	AzoxymethaneIBA 08/2017
1	Erythromycin (Erycette)FDA LinkGeneric 05/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2017
1	irsogladineIBA 02/2016
1	Cholesterol Esters (Cholesteryl Esters)IBA 07/2013
1	Macrophage Migration-Inhibitory FactorsIBA 10/2012
1	Cysteine (L-Cysteine)FDA Link 10/2012
1	Proline (L-Proline)FDA Link 10/2012
1	Glutathione (Reduced Glutathione)IBA 10/2012
1	isothiocyanic acidIBA 10/2012
1	Sucrose (Saccharose)IBA 09/2012
1	Drinking WaterIBA 09/2012
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 09/2012
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2012
1	LipopolysaccharidesIBA 12/2011